Lucid Diagnostics Inc

+0.01 (+0.45%)
Earnings Announcements

Lucid Diagnostics Inc Says For Q4 Esoguard Related Revenues Were $0.3 Mln

Published: 03/28/2022 21:49 GMT
Lucid Diagnostics Inc (LUCD) - For Q4 of 2021, Esoguard Related Revenues Were $0.3 Million.
Cash and Cash Equivalents of $53.7 Million As of December 31, 2021.
Qtrly Non-GAAP Adjusted Loss per Share $0.22.
Q4 Earnings per Share View $-0.20, Revenue View $402400.00 -- Refinitiv Ibes Data (analyst estimates).
Qtrly GAAP Net Loss $0.32 per Share.
Revenue is expected to be $0.71 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $1.43 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.